(Q24626194)
Statements
A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer (English)
0 references
August 2012
0 references
134
0 references
3
0 references
1149-59
0 references
1 reference
1 reference
1 reference